JP2020519628A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519628A5
JP2020519628A5 JP2019562284A JP2019562284A JP2020519628A5 JP 2020519628 A5 JP2020519628 A5 JP 2020519628A5 JP 2019562284 A JP2019562284 A JP 2019562284A JP 2019562284 A JP2019562284 A JP 2019562284A JP 2020519628 A5 JP2020519628 A5 JP 2020519628A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
antiarrhythmic
effective amount
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019562284A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519628A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/032092 external-priority patent/WO2018209107A1/en
Publication of JP2020519628A publication Critical patent/JP2020519628A/ja
Publication of JP2020519628A5 publication Critical patent/JP2020519628A5/ja
Priority to JP2023071974A priority Critical patent/JP2023100743A/ja
Pending legal-status Critical Current

Links

JP2019562284A 2017-05-10 2018-05-10 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法 Pending JP2020519628A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023071974A JP2023100743A (ja) 2017-05-10 2023-04-26 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762504292P 2017-05-10 2017-05-10
US62/504,292 2017-05-10
PCT/US2018/032092 WO2018209107A1 (en) 2017-05-10 2018-05-10 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023071974A Division JP2023100743A (ja) 2017-05-10 2023-04-26 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法

Publications (2)

Publication Number Publication Date
JP2020519628A JP2020519628A (ja) 2020-07-02
JP2020519628A5 true JP2020519628A5 (enExample) 2021-06-10

Family

ID=64096874

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019562284A Pending JP2020519628A (ja) 2017-05-10 2018-05-10 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法
JP2023071974A Pending JP2023100743A (ja) 2017-05-10 2023-04-26 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023071974A Pending JP2023100743A (ja) 2017-05-10 2023-04-26 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法

Country Status (9)

Country Link
US (5) US10441537B2 (enExample)
EP (1) EP3621616A4 (enExample)
JP (2) JP2020519628A (enExample)
KR (1) KR20200003199A (enExample)
CN (1) CN110869018A (enExample)
AU (1) AU2018266199A1 (enExample)
CA (1) CA3060702A1 (enExample)
IL (1) IL270407B2 (enExample)
WO (1) WO2018209107A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3411030A4 (en) 2016-02-01 2019-09-04 InCarda Therapeutics, Inc. ELECTRONIC MONITORING WITH INHERENT PHARMACOLOGICAL THERAPY FOR THE MANAGEMENT OF HERZARRYTHMIAS WITH VORHOFFLIMMERN
ES3040411T3 (en) 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
US11020384B2 (en) 2019-08-01 2021-06-01 Incarda Therapeutics, Inc. Antiarrhythmic formulation
IL290088B2 (en) * 2019-08-01 2023-10-01 Incarda Therapeutics Inc A pharmaceutical preparation containing flacainide, cyclodextrin and acid, a dosage unit of the preparation and a kit containing the preparation
CN111595112B (zh) * 2020-05-26 2022-02-08 内蒙古铂贝曼科技有限公司 一种粉末磷脂的制备方法
AU2021400335A1 (en) 2020-12-17 2023-06-22 Incarda Therapeutics, Inc. Kits and methods for induction of cardioversion in subjects with atrial arrhythmias
US20240252431A1 (en) * 2021-07-20 2024-08-01 Onconox Inc. Pulmonary biguanide formulations and delivery devices

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1001029A (en) 1911-01-03 1911-08-22 Paul E Herrmann Hair-curler.
US1004593A (en) 1911-03-25 1911-10-03 Catherine Ryan Measuring device for cutting garments.
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
SE408265B (sv) 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
US4247066A (en) 1978-02-21 1981-01-27 General Dynamics Corporation Airfoil variable cambering device and method
IT1116047B (it) 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
US4930518A (en) 1988-09-26 1990-06-05 Hrushesky William J M Sinus arrhythmia monitor
US4962095A (en) 1989-02-15 1990-10-09 E. R. Squibb & Sons, Inc. Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
CA2112674C (en) 1991-07-02 2005-10-04 John S. Patton Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JPH10501519A (ja) 1994-03-07 1998-02-10 インヘイル・セラピューティック・システムズ インシュリンを肺に送給できる方法および組成物
CA2190502A1 (en) 1994-05-18 1995-11-23 Robert M. Platz Methods and compositions for the dry powder formulation of interferons
JP3388896B2 (ja) 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
WO1996032096A1 (en) 1995-04-14 1996-10-17 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
AU5806898A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems Processes and compositions for spray drying hydrophobic drugs in organic solventsuspensions of hydrophilic excipients
NZ503464A (en) 1997-09-29 2002-05-31 Inhale Therapeutic Syst Perforated microparticles containing a bioactive agent for pulmonary delivery
WO1999016420A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in nebulizers
US20020017295A1 (en) 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6541479B1 (en) 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
DE19835346A1 (de) 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
NZ511568A (en) 1998-11-12 2003-08-29 Frank G An inhalation system using lipids for the delivery of bioactive compounds
JP4377076B2 (ja) 1999-05-28 2009-12-02 ネクター セラピューティクス 噴霧化された薬物の計量された量を投与する装置と方法
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6357490B1 (en) 2000-08-22 2002-03-19 Advanced Inhalation Research, Inc. System, method and apparatus for filling containers
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
KR100743404B1 (ko) 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달
WO2002080859A2 (en) 2001-03-20 2002-10-17 Glaxo Group Limited Inhalation drug combinations
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20080038363A1 (en) 2001-05-24 2008-02-14 Zaffaroni Alejandro C Aerosol delivery system and uses thereof
WO2003026559A2 (en) 2001-09-28 2003-04-03 Kurve Technology, Inc Nasal nebulizer
NZ536001A (en) 2002-04-18 2006-05-26 Cv Therapeutics Inc Method of treating arrhythmias comprising administration of an A1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
US7607436B2 (en) 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7334580B2 (en) 2002-05-07 2008-02-26 Smaldone Gerald C Methods, devices and formulations for targeted endobronchial therapy
EP2647400A1 (en) 2002-05-07 2013-10-09 The State University of New York at Stony Brook Devices for targeted endobronchial therapy
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
PL378270A1 (pl) 2002-12-31 2006-03-20 Nektar Therapeutics Preparat farmaceutyczny zawierający nierozpuszczalny środek czynny
WO2004100964A1 (en) 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
US7674820B2 (en) 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
US7967756B2 (en) 2003-09-18 2011-06-28 Cardiac Pacemakers, Inc. Respiratory therapy control based on cardiac cycle
EP1718356B1 (en) 2004-02-25 2016-09-21 Resmed Limited Cardiac monitoring and therapy using a device for providing pressure treatment of sleep disordered breathing
CA2464029A1 (en) 2004-04-08 2005-10-08 Valery Telfort Non-invasive ventilation monitor
US20060034906A1 (en) 2004-05-21 2006-02-16 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20060120962A1 (en) * 2004-10-12 2006-06-08 Rabinowitz Joshua D Cardiac safe, rapid medication delivery
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
EP1951672B1 (en) 2005-10-21 2011-05-25 Merck Sharp & Dohme Corp. Potassium channel inhibitors
ITMI20051999A1 (it) 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
CA2667225C (en) 2006-10-25 2015-06-09 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
WO2008066745A1 (en) 2006-11-22 2008-06-05 Reliant Pharmaceuticals, Inc. Prophlyaxis and treatment of atrial fibrillation with omega-3 fatty acids
TW200840578A (en) 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
WO2008134630A1 (en) 2007-04-30 2008-11-06 Apt Pharmaceuticals Dexrazoxane compounds for cardioprotection
US20080275036A1 (en) 2007-05-02 2008-11-06 Apt Pharmaceuticals, Inc. Prevention and treatment of cardiac conditions
CN101467968A (zh) 2007-12-24 2009-07-01 浙江正方医药科技有限公司 抗心律失常药物的新给药途径的制剂
WO2010019914A2 (en) 2008-08-14 2010-02-18 The Uab Research Foundation Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre
CA2734780C (en) 2008-08-22 2016-07-05 Milestone Pharmaceuticals Inc. Short acting benzothiazepine calcium channel blockers and uses thereof
JP5730316B2 (ja) 2008-09-23 2015-06-10 ラボラトリー スキン ケア インコーポレイテッド 活性剤を充填した、均一、硬質、球状のナノ多孔質リン酸カルシウム粒子の製造方法
ES3003038T3 (en) 2009-03-18 2025-03-10 Incarda Therapeutics Inc Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
AU2016256776B2 (en) 2009-03-18 2018-04-12 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
AU2013248242B2 (en) * 2009-03-18 2016-08-18 Incarda Therapeutics, Inc Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
ITRM20110390A1 (it) 2011-07-21 2013-01-22 Eramo Alessandra D Prodotto per stimolare la produzione endogena di mediatori dell'infiammazione.
EP3411030A4 (en) 2016-02-01 2019-09-04 InCarda Therapeutics, Inc. ELECTRONIC MONITORING WITH INHERENT PHARMACOLOGICAL THERAPY FOR THE MANAGEMENT OF HERZARRYTHMIAS WITH VORHOFFLIMMERN

Similar Documents

Publication Publication Date Title
JP2020519628A5 (enExample)
JP7071949B2 (ja) 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2015193657A5 (enExample)
JP2017160268A5 (enExample)
US20230092389A1 (en) Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
ITMI20002556A1 (it) Impiego di composti organici nel trattamento di malattie
CN106420676B (zh) 作为气溶胶团的伊洛前列素的给药
HUP0101737A2 (hu) Eljárások és készítmények raloxifén tüdőn és orron át történő beadására
JP2003516926A5 (ja) コーティングされた薬物粒子からなる薬剤、製剤、治療用キット、製剤の使用、及び薬物粒子を調製するための方法
JP2025004215A (ja) 抗不整脈製剤
CN104853744B (zh) 气溶胶化伊洛前列素的给药
JPH10500966A (ja) 経口吸入もしくは吹き込みにより投与する為の化合物、及び組成物
ES3040411T3 (en) A novel method to slow ventricular rate
KR20230035518A (ko) 선천적 면역 반응을 생성하기 위한 퀴닌과 그의 용도
KR102891439B1 (ko) 항부정맥 제제
EP3801738A1 (en) Methods for diagnosing brugada syndrome using an aerosol
JPWO2022204328A5 (enExample)
KR20250171439A (ko) 항부정맥 제제
HK1190627B (en) Administration of iloprost as aerosol bolus